Smaregi, Inc.
Smaregi, Inc. Fundamental Analysis
Smaregi, Inc. (4431.T) shows strong financial fundamentals with a PE ratio of 21.69, profit margin of 15.09%, and ROE of 23.71%. The company generates $12.8B in annual revenue with strong year-over-year growth of 31.97%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 81.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 4431.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent4431.T demonstrates superior asset utilization.
Valuation Score
Excellent4431.T trades at attractive valuation levels.
Growth Score
Excellent4431.T delivers strong and consistent growth momentum.
Financial Health Score
Excellent4431.T maintains a strong and stable balance sheet.
Profitability Score
Moderate4431.T maintains healthy but balanced margins.
Key Financial Metrics
Is 4431.T Expensive or Cheap?
P/E Ratio
4431.T trades at 21.69 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 4431.T's PEG of 1.90 indicates fair valuation.
Price to Book
The market values Smaregi, Inc. at 4.70 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 14.24 times EBITDA. This signals the market has high growth expectations.
How Well Does 4431.T Make Money?
Net Profit Margin
For every $100 in sales, Smaregi, Inc. keeps $15.09 as profit after all expenses.
Operating Margin
Core operations generate 21.66 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $23.71 in profit for every $100 of shareholder equity.
ROA
Smaregi, Inc. generates $15.01 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Smaregi, Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Smaregi, Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
4431.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.69
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.90
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.70
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.27
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.01
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.76
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.24
vs 25 benchmark
ROA
Return on assets percentage
0.15
vs 25 benchmark
ROCE
Return on capital employed
0.30
vs 25 benchmark
How 4431.T Stacks Against Its Sector Peers
| Metric | 4431.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.69 | 33.61 | Better (Cheaper) |
| ROE | 23.71% | 1020.00% | Weak |
| Net Margin | 15.09% | -56528.00% (disorted) | Strong |
| Debt/Equity | 0.01 | 0.45 | Strong (Low Leverage) |
| Current Ratio | 2.76 | 5.65 | Strong Liquidity |
| ROA | 15.01% | -291484.00% (disorted) | Strong |
4431.T outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Smaregi, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
233.34%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
193.33%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
230.49%
Industry Style: Growth, Innovation, High Beta
High Growth